This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2022.
All research outputs
#2,434,084
of 28,768,344 outputs
Outputs from EMBO Molecular Medicine
#520
of 1,834 outputs
Outputs of similar age
#58,411
of 539,259 outputs
Outputs of similar age from EMBO Molecular Medicine
#19
of 45 outputs
Altmetric has tracked 28,768,344 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,834 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 539,259 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
